Prevalence and Clinical Characteristics of Aspirin Resistance in the Patients with Type 2 Diabetes Mellitus
Open Access
- 1 January 2008
- journal article
- Published by Korean Diabetes Association in Korean Diabetes Journal
- Vol. 32 (1) , 53-59
Abstract
No abstract availableThis publication has 20 references indexed in Scilit:
- Aspirin resistanceThe Lancet, 2006
- Prevalence of aspirin resistance in patients with type 2 diabetesActa Diabetologica, 2005
- A prospective, blinded determination of the natural history of aspirin resistance among stable patients with cardiovascular diseaseJACC, 2003
- Aspirin-Resistant Thromboxane Biosynthesis and the Risk of Myocardial Infarction, Stroke, or Cardiovascular Death in Patients at High Risk for Cardiovascular EventsCirculation, 2002
- Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patientsBMJ, 2002
- Aspirin Resistance in Cardiovascular Disease: A Review of Prevalence, Mechanisms, and Clinical SignificanceThrombosis and Haemostasis, 2002
- Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general PracticeThe Lancet, 2001
- Long-Term Complications of Diabetes MellitusNew England Journal of Medicine, 1993
- Diabetes as an atherogenic factorProgress in Cardiovascular Diseases, 1984
- Platelet aggregation studies in coronary artery diseaseAtherosclerosis, 1978